EQRx to Hold Fourth Quarter and Full Year 2021 Financial Results Conference Call on Wednesday, March 23, 2022
March 09 2022 - 8:00AM
EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company
committed to developing and delivering innovative medicines to
patients at radically lower prices, today announced it will host a
conference call and webcast on Wednesday, March 23, 2022, at 8:00
a.m. ET to report its fourth quarter and full year 2021 financial
results and provide a business update.
A live webcast can be accessed by visiting the Investors section
of the Company’s website at investors.eqrx.com. The conference call
can be accessed by dialing 855-718-8094 (domestic) or 484-747-6788
(international) and referring to conference ID 4596972. The webcast
will be made available for replay on the Company's website
beginning approximately two hours after the event.
About EQRxEQRx is a new type of pharmaceutical
company committed to developing and delivering innovative medicines
to patients at radically lower prices. Launched in January 2020,
EQRx is purpose-built, at scale, with a growing catalog of
medicines in development in high-cost drug categories and emerging
partnerships with leading payers and providers. Leveraging
cutting-edge science and technology and strategic partnerships with
stakeholders from across the healthcare system, EQRx aims to
provide innovative, patent-protected medicines more efficiently and
cost-effectively than ever before. To learn more, visit
www.eqrx.com and follow us on social media:
Twitter: @EQRxInc, LinkedIn,
Instagram: @eqrxinc.
EQRx™ and Remaking Medicine™ are trademarks of EQRx.
EQRx Contacts:
Media:Dan Budwick1ABdan@1abmedia.com
Investors:investors@eqrx.com
EQRx (NASDAQ:EQRX)
Historical Stock Chart
From Apr 2024 to May 2024
EQRx (NASDAQ:EQRX)
Historical Stock Chart
From May 2023 to May 2024